Resveratrol inhibits KSHV reactivation by lowering the levels of cellular Egr-1

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Dyson, Ossie F ^a   Walker, Lia R ^a   Whitehouse, Adrian ^b   Cook, Paul P ^a   Akula, Shaw M ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE; ORF50 PROTEIN; RAF PROTEIN; RESVERATROL; UNCLASSIFIED DRUG; VIRUS PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; IMMEDIATE EARLY PROTEIN; LUCIFERASE; PRIMER DNA; RTA PROTEIN, HUMAN HERPESVIRUS 8; STILBENE DERIVATIVE; TRANSACTIVATOR PROTEIN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; GC RICH SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENE REPLICATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; MOLECULAR MECHANICS; NONHUMAN; ORF50 GENE; PATHOGENESIS; PROMOTER REGION; VIRUS GENE; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; CELL STRAIN HEK293; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIRUS ACTIVATION; WESTERN BLOTTING;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; EARLY GROWTH RESPONSE PROTEIN 1; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HEK293 CELLS; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; LUCIFERASES; REAL-TIME POLYMERASE CHAIN REACTION; STILBENES; TRANS-ACTIVATORS; VIRUS ACTIVATION;

EID: 84858027052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033364     Document Type: Article

References (47)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
2. Ackermann M, (2006) Pathogenesis of gammaherpesvirus infections. Vet Microbiol 113: 211-222.
3. de Sanjose S, Mbisa G, Perez-Alvarez S, Benavente Y, Sukvirach S, et al. (2009) Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 199: 1449-1456.
4. Chen L, Lagunoff M, (2005) Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells. J Virol 79: 14383-14391.
5. Lukac DM, Kirshner JR, Ganem D, (1999) Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73: 9348-9361.
6. Dyson OF, Traylen CM, Akula SM, (2010) Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1. J Biol Chem 285: 37491-37502.
7. Knapska E, Kaczmarek L, (2004) A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK? Prog Neurobiol 74: 183-211.
8. Gashler A, Sukhatme VP, (1995) Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 50: 191-224.
9. Thiel G, Cibelli G, (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193: 287-292.
10. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, et al. (1996) Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2: 342-346.
11. McCoy C, Smith DE, Cornwell MM, (1995) 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol Cell Biol 15: 6100-6108.
12. Ford PW, Bryan BA, Dyson OF, Weidner DA, Chintalgattu V, et al. (2006) Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency. J Gen Virol 87: 1139-1144.
13. Cohen A, Brodie C, Sarid R, (2006) An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. J Gen Virol 87: 795-802.
14. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783-2840.
15. Beck H, Semisch M, Culmsee C, Plesnila N, Hatzopoulos AK, (2008) Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke. Am J Pathol 173: 77-92.
16. Cao X, Mahendran R, Guy GR, Tan YH, (1993) Detection and characterization of cellular EGR-1 binding to its recognition site. J Biol Chem 268: 16949-16957.
17. Cai Y, Liu Y, Zhang X, (2006) Induction of transcription factor Egr-1 gene expression in astrocytoma cells by Murine coronavirus infection. Virology 355: 152-163.
18. Romagnoli L, Sariyer IK, Tung J, Feliciano M, Sawaya BE, et al. (2008) Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology 375: 331-341.
19. Katsarou K, Lavdas AA, Tsitoura P, Serti E, Markoulatos P, et al. (2010) Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events. Cell Mol Life Sci 67: 2491-2506.
20. Bedadala GR, Palem JR, Graham L, Hill JM, McFerrin HE, et al. (2011) Lytic HSV-1 infection induces the multifunctional transcription factor Early Growth Response-1 (EGR-1) in rabbit corneal cells. Virol J 8: 262.
21. Chang Y, Moore PS, (1996) Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 5: 215-222.
22. Glaunsinger B, Ganem D, (2004) Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol Cell 13: 713-723.
23. De Leo A, Arena G, Stecca C, Raciti M, Mattia E, (2011) Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program. Mol Cancer Res 9: 1346-1355.
24. Matsumura S, Fujita Y, Gomez E, Tanese N, Wilson AC, (2005) Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J Virol 79: 8493-8505.
25. Fagone E, Conte E, Gili E, Fruciano M, Pistorio MP, et al. (2011) Resveratrol inhibits transforming growth factor-beta-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Exp Lung Res 37: 162-174.
26. Lee SJ, Kim MM, (2011) Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells. Life Sci 88: 465-472.
27. Yiu CY, Chen SY, Chang LK, Chiu YF, Lin TP, (2010) Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle. Molecules 15: 7115-7124.
28. Bryan BA, Dyson OF, Akula SM, (2006) Identifying cellular genes crucial for the reactivation of Kaposi's sarcoma-associated herpesvirus latency. J Gen Virol 87: 519-529.
29. Yu F, Harada JN, Brown HJ, Deng H, Song MJ, et al. (2007) Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog 3: e44.
30. Sauer L, Gitenay D, Vo C, Baron VT, (2010) Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells. Oncogene 29: 2628-2637.
31. Cai Q, Verma SC, Choi JY, Ma M, Robertson ES, (2010) Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency. J Virol 84: 11134-11144.
32. Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, et al. (2003) NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77: 8532-8540.
33. Yu F, Feng J, Harada JN, Chanda SK, Kenney SC, et al. (2007) B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett 581: 3485-3488.
34. Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ, (2006) Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells. Antiviral Res 72: 242-251.
35. Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T, (2006) Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res 72: 171-177.
36. Krishnan V, Zeichner SL, (2004) Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J Virol 78: 9458-9473.
37. Nakamura M, Saito H, Ikeda M, Hokari R, Kato N, et al. (2010) An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. World J Gastroenterol 16: 184-192.
38. Shukla Y, Singh R, (2011) Resveratrol and cellular mechanisms of cancer prevention. Ann N Y Acad Sci 1215: 1-8.
39. Hua J, Guerin KI, Chen J, Michan S, Stahl A, et al. (2011) Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. Invest Ophthalmol Vis Sci 52: 2809-2816.
40. Venkatesan B, Valente AJ, Reddy VS, Siwik DA, Chandrasekar B, (2009) Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration. Am J Physiol Heart Circ Physiol 297: H874-886.
41. Yu HW, Liu QF, Liu GN, (2010) Positive regulation of the Egr-1/osteopontin positive feedback loop in rat vascular smooth muscle cells by TGF-beta, ERK, JNK, and p38 MAPK signaling. Biochem Biophys Res Commun 396: 451-456.
42. Ke J, Gururajan M, Kumar A, Simmons A, Turcios L, et al. (2006) The role of MAPKs in B cell receptor-induced down-regulation of Egr-1 in immature B lymphoma cells. J Biol Chem 281: 39806-39818.
43. Ford PW, Hamden KE, Whitman AG, McCubrey JA, Akula SM, (2004) Vascular Endothelial Growth Factor Augments Human Herpesvirus-8 (HHV-8/KSHV) Infection. Cancer Biol Ther 3.
44. Akula SM, Pramod NP, Wang FZ, Chandran B, (2002) Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108: 407-419.
45. Akula SM, Pramod NP, Wang FZ, Chandran B, (2001) Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology 284: 235-249.
46. Dyson OF, Oxendine TL, Hamden KE, Ford PW, Akula SM, (2008) Differential regulation of the attachment of Kaposi's sarcoma-associated herpesvirus (KSHV)-infected human B cells to extracellular matrix by KSHV-encoded gB and cellular alphaV integrins. Cell Microbiol 10: 1546-1558.
47. Dyson OF, Bryan BA, Lambert PJ, Ford PW, Akula SM, (2007) beta1 Integrins Mediate Tubule Formation Induced by Supernatants Derived from KSHV-Infected Cells. Intervirology 50: 245-253.